Daily News logo Newsletter logo   Search News    

Aeon Astron Europe B.V., Receives Grants Up to EURO 500,000 from AgentschapNL, Dept. of Economic Affairs of the Netherlands for Its Biolens Project

  Share This Story

LEIDEN, Netherlands, Feb. 15, 2012 /PRNewswire-Asia/ -- Aeon Astron Europe B.V., has been awarded a governmental grant up to EURO 500,000 from AgentschapNL, Dept. of Economic Affairs of the Netherlands for its Biolens projects to begin development of a multipurpose collagen-based ophthalmic lens for use in refractive correction, corneal repair and drug carrier. The AgentschapNL program is an initiative of the Dept. of Economic Affairs of the Netherlands to encourage development of bold and unconventional global health solutions.

Aeon Astron Europe B.V. was encouraged to propose a breakthrough development for the production of a unique multipurpose ophthalmic lens, which is made from naturally occurring collagen into a transparent and biocompatible form of a contact lens that can easily be placed on the surface of the eye. The future of this collagen-based Biolens is highly promising. The unique feature of providing corneal protection, refractive correction, drug delivery and the potential for better and faster wound healing may eventually make this Biolens a standard part of ophthalmic practice.

"We are honored that our innovative plan to produce a unique, multipurpose ophthalmic lens has been recognized by the Netherlands government with the award of a highly competitive grant. Based on our long experience in the research of bio-scaffolds for regenerative solutions, we have high expectations for significant success after our 3 year struggle to introduce this first-in-class ophthalmic lens to benefit worldwide ophthalmic patients," said Mr. Michael H.J., Lai, the Chairman and company CEO.

About Aeon Astron Europe B.V.

Aeon Astron Europe B.V. is a privately held international biotech company based in the Netherlands. At Aeon Astron, we are dedicated to discovering, developing, producing and marketing of state-of-art regenerative solutions to save lives and restore health. We serve the medical community around the world to help medical professionals advance the standard of care to meet unmet medical needs for patients. As a global provider of regenerative solutions, our product pipeline expands across the fields of ophthalmology, dentistry, orthopedic and general and plastic surgery, including Biocornea, Biolens, Biobone, long-lasting dermal filler and 2-in-1 dental plug membrane among others.

More information on Aeon Astron Europe B.V. is available at http://www.aeonastron.com/aeon01.php.

SOURCE Aeon Astron Europe B.V.



 
Support Wikipedia

NeswBlaze top writers

Find more stories recommended by Stumbleupon.

newsletter logo

What's Hot?
1 .Supermodel Bar Refaeli Adorns the Cover of the 2009 Sports Illustrated Swimsuit Issue on Newsstands Today! - 105
2 .Breaking News: Cannes Film Festival Awards 2012 - 78
3 .Calling All Military Supporters: a Supporter Needs Your Vote to Win a Grant - 68
4 .Is It Coincidental We Have Another Missing Petite Blonde Coed, Mickey Shunick? - 38
5 .Give a Great Valedictorian Speech - Joey Asher - 33
6 .Round up of iPhone 5 Rumors From the Armenante Apple News Blog - 34
7 .Waterless 'Air Cooler PLUS' Beats Summer's Heat Without Making Your Home Muggy - 38
8 .These 10 Comfortable Walking Shoes Are a Step in the Right Direction - 30
9 .Ethiopia Celebrates Downfall of the Derg Day - 26
10 .Very Young Girls Movie Review: Sex, Class and Ho Daddies - 25
Updated: 14:15 PDT     3675

NewsBlaze Editors

editors

NewsBlaze Writers

news writer images

Writers Wanted

Help NewsBlaze provide daily news, including top stories, Home and Garden, Technology, The Environment and more. NewsBlaze Writer

Follow NewsBlaze

NewsBlaze Social Media Logos NewsBlaze Facebook NewsBlaze LinkedIn NewsBlaze Twitter NewsBlaze YouTube NewsBlaze MySpace NewsBlaze Fan Page NewsBlaze StumbleUpon NewsBlaze Political Cartoons NewsBlaze Editorial Cartoons
NewsBlaze 
Copyright © 2004-2012 NewsBlaze LLC
Use of this website is subject to our Terms of Service and Privacy Policy  | DMCA Notice |         Press Room